The role of FHL-2 in tumors is bidirectional, whereby overexpression of FHL-2 has been observed in colorectal, gastric, and pancreatic cancer, while it has been reported to be downregulated in HCC (Verset et al., 2016). Here, FHL2 is linked to familial pancreatic carcinoma.